Skip to content

A clinical study on PERUNGAYA CHOORANAM in the management of VATHA GUNMAM (PEPTIC ULCER)

A Prospective open labelled Non randomized phase II clinical Trial of PERUNGAYA CHOORANAM in the management of VATHA GUNMAM (PEPTIC ULCER)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031266
Enrollment
60
Registered
2021-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation

Interventions

Intervention1: PERUNGAYA CHOORANAM: 6.3g twice a day after meals for 30 days in 60 patients Control Intervention1: Not applicable: Not applicable

Sponsors

Government Siddha Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having symptoms of fatigue & weakness, constipation,general body pain,tiredness drowsiness,heaviness of body, loss of appetite,loss of strength, vomiting,dryness of the tongue,headache,heartburn,and indigestion patients who are willing to take upper gastro-intestinal endoscopy patient who are willing to give blood specimen for laboratory investigation when required patient willing to sign the informed consent indicating that they understand the purpose and procedures required for the study and are willing to participate in the study

Exclusion criteria

Exclusion criteria: Pregnancy Lactating mother Recent malignancy or radiation therapy Gastro esophageal reflux diseases Pancreatitis Inflammatory bowel disease acute hepatitis patients considered unreliable by the investigator(e.g.,drug addiction, alcohol abuse)

Design outcomes

Primary

MeasureTime frame
The outcome is reduction in clinical symptoms of Epigastric pain,Heart burn,Fatigue & Weakness, Constipation, General body pain,Tiredness-Drowsiness,Heaviness of Body,Loss of appetite, Loss of strength,Vomiting,Dryness of the tongue,Headache and IndigestionTimepoint: 30 Days

Secondary

MeasureTime frame
To evaluate siddha parameters (including Envagai thervu) changes in VATHA GUNMAM during the trial periodTimepoint: 30 days

Countries

India

Contacts

Public ContactDrAManoharan MDSPhD

Government Siddha Medical College and Hospital,Palayamkottai,Tirunelveli,Tamil Nadu

komalaarumugam1@gmail.com8248497477

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026